More importantly, we identified a subgroup of patients with colorectal CA with a very poor prognosis compared to other CA patients, suggesting that elevated preoperative serum CEA in colorectal CA should receive greater attention from oncologists. The gene discussed is CEACAM5; the disease is cancer.